# Trade Mark Journal No.2026/010 6 March 2026

## WO0000001902116 (1,5)

Office of origin: United States of America

Date of International Registration:13 November 2025
Date of designation in the UK: 13 November 2025

International priority date claimed: 23 May 2025 (United States of America) (99200644)

Class 1
  Active chemical ingredients for use in the manufacture of anti-cancer drugs.
Class 5
  Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer.

GEROSYNTH LABORATORIES, INC.

Representative: Greg Gronholm GRONHOLM PATENT SERVICES, 96 Craig St, Suite 112-318, East Ellijay GA 30540, UNITED STATES OF AMERICA